The molecular basis of ALK immunoreactivity observed in diverse fusion-associated soft tissue tumors seems heterogeneous and associates with specific types of fusions (e.g., EWSR1/FUS-TFCP2 and EWSR1 but not MEIS1-NCOA2 and other fusions [11, 12]). The gene discussed is NCOA2; the disease is soft tissue neoplasm.